American Association of Clinical Endocrinology Annual Meeting 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Endocrinologists, Cardiologists, Lipidologists, Nephrologists, Hepatologists, Primary Care Physicians, and Obesity Medicine Specialists

+ Sample video: contact me for sample video

+ Information:

The American Association of Clinical Endocrinology (AACE) Annual Meeting 2026 is scheduled to be held from April 22 to 24, 2026, at Caesars Forum in Las Vegas, Nevada. As a premier clinical endocrinology conference, it provides endocrinologists and patient care team members with practical applications of the latest practice guidelines and scientific discoveries. The event features live cases, expert-led sessions, and hands-on workshops focused on diagnosing and treating various endocrine-related disorders, offering up to 47.25 CME/CE/MOC credits.

Learning Objectives

Upon completion of the meeting, participants should be able to:

• Discuss the latest scientific and clinical discoveries in the fields of endocrinology, diabetes, and metabolism.

• Apply newfound knowledge to diagnosis and management for improved patient outcomes.

• Assess the potential applications of emerging scientific advances that affect the practice of endocrinology.

• Empower participants to educate their patients regarding clinical treatment options.

Target Audience

• This program is intended for medical professionals from the field of clinical endocrinology at all stages in their career including clinical endocrinologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, registered dietitians, medical students, residents, and fellows in.
• Best for Endocrinologists, Cardiologists, Lipidologists, Nephrologists, Hepatologists, Primary Care Physicians, and Obesity Medicine Specialists.

Topics

Bone and Parathyroid

• CKD Related Metabolic Bone Disease

• Hypoparathyroidism Diagnosis and Management, What the Guidelines Tell Us

• Hormone Therapy in the Prevention and Treatment of Osteoporosis

• Anabolic First or Bisphosphonate First Rethinking the Initial Approach to Treatment

• Nutrition and Skeletal Health

• Rare Bone Disorders Primer for Diagnosis and Treatment

• DSN Year in Review- Bone

Diabetes and Diabetes Technology

• AACE 2026 Algorithm for Management of Adults with Type 2 Diabetes

• Global Perspectives on Diabetes and Obesity

• Cell Therapies in T1DM Are We Close to a Cure

• Continuous Ketone Monitoring Current State of Affairs and Potential Clinical Implications

• Insulin Pumps for Type 2 Diabetes

• Should CGM Be Used for Gestational Diabetes

• Perioperative Management of Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery (AID) Systems

• DSN Year in Review Diabetes

• AI’s Transformation in Diabetes Care

• Atypical Diabetes in Focus- Advances in the Pathophysiology and Management of PTD and CFRD

• Where Are We With Weekly Insulin The Pros and Cons

• Early-Stage Type 1 Diabetes- Screening, Monitoring, Treatments and Future Directions (Alan J. Garber, MD Lectureship)

• Advances in Prediabetes and Diabetes Prevention

Thyroid

• Exploring the Connection between Nutrition and Thyroid Health

• Updates to Thyroid Nodules and Cancer Guidelines

• Impact of Iodine on Thyroid Autoimmunity, Goiter and Oncogenesis (Hossein Gharib, MD, Lectureship)

• Minimally Invasive Management of Thyroid Nodules

• Optimal Thyroid Hormone Replacement in Thyroid Cancer

• Challenging Benign and Malignant Thyroid Cases

• Drug-Induced Thyroid Dysfunctions

• DSN Year in Review- Thyroid

• Deconstructing the TSH Feedback Loop- Integrating Deiodinase Biology into the Management of Hypothyroidism

Cardiovascular, Cardiometabolic, and Lipids

• Lp(a)- What Every Endocrinologist Needs to Know Now — and What’s Coming

• DSN Year in Review- Cardiometabolic and Lipids

• Cardiovascular Risk Management in Patients with Type 1 Diabetes Mellitus with Focus on Lipids

• Cracking the Code- Uncovering Hidden Cardiometabolic Risk in South Asians 2

• From Insight to Action- Tackling the MASLD and MASH Epidemic

• Optimizing Dyslipidemia Management- Application of the AACE Algorithm to Patient Care

• Multidisciplinary Approach to MASLD and MASH

Pituitary, Gonad, Adrenal, Neuroendocrine

• To Treat or Not to Treat Cases of Functional Hypogonadism

• Personalized Treatments for Acromegaly 1

• Un-Conn-Trollable Aldosterone- Updates in the Screening and Management of Hyperaldosteronism

• Is Pheochromocytoma the Correct Diagnosis for the Patient A State-of-the-Art Evaluation

• DSN Year in Review- PGAN

• PCOS- An Evidence-Based Approach to Comprehensive Management in 2026

• Pituitary Masses Requiring Surgery- Pre and Postoperative Endocrine Considerations

• The Indeterminate Adrenal Mass

Obesity and Nutrition

• Should We Continue to Use BMI When Talking About Obesity

• The Do’s and Don’ts of Microdosing GLP-1 RA

• Keynote- Nutrition and Chronic Disease- A Hero’s Journey in AACE

• Menopause- Overcoming Changes in Metabolism & Weight

• Beyond Type 2- Evaluating GLP-1 Use in Type 1 Diabetes and Obesity 1

• Pediatric Obesity- From Diagnosis to Long-Term Care

• DSN Year in Review- Nutrition & Obesity

• Exercise and Nutrition Recommendations for Patients on GLP-1 RA GIP Agents to Decrease Sarcopenia

• Obesity Management Across Solid Organ Transplantation- Kidney, Liver and Heart

Non-Clinical Professional Development

• Triaging Endocrine Referrals- Tackling the Access Dilemma

• Reclaiming the Narrative- EHR Optimization to Reclaim the Joy in Medicine

• Making AI Work for You Practical Applications in the Endocrine Clinic

• Advancing Endocrine Education- Graduated Responsibility and Precision Learning